Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

European First in Human Study of the NeoChord Transcatheter Mitral Repair System to Assess Safety and Performance in Patients With Symptomatic Mitral Regurgitation

NCT05425628 is registered in ClinicalTrials.gov with NeoChord as lead sponsor.

NCT NCT05425628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05425628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
European First in Human Study of the NeoChord Transcatheter Mitral Repair System to Assess Safety and Performance in Patients With Symptomatic Mitral Regurgitation
Lead sponsor
NeoChord
Phase
Not applicable
Overall status
Unknown status
Start date
August 1, 2022
Completion date
December 1, 2023
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, degenerative, heart diseases, heart valve diseases, mitral regurgitation, mitral valve insufficiency, mitral valve prolapse